Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States.
$2.85+10.47%
报价 2026-11-06
市值
$556.6M
EV
$558M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -3.7%
$1.20$2.96
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-07不在筛选范围：industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| OVIDOvid Therapeutics Inc. | $556.6M | +10.5% | -97.0% | 100% | – | – | – | |
| STTKShattuck Labs, Inc. | $463.7M | +2.9% | +33.3% | -82% | – | – | – | |
| IFRXInflaRx N.V. | $192.3M | -3.7% | – | 48,201.6% | – | – | – | |
| WHWKWhitehawk Therapeutics Inc | $178.4M | +3.6% | +23.9% | 0% | – | – | – | |
| ORMPOramed Pharmaceuticals Inc. | $160.6M | -0.8% | -40.0% | 0% | 1.9x | 2.4x | – | |
| MGNXMacroGenics, Inc. | $148.4M | +5.0% | -21.0% | 50.4% | – | – | – | |
| KLRSKalaris Therapeutics Inc | $57.6M | +2.5% | -100.0% | 0% | – | – | – | |
| CLNNClene Inc. | $56.1M | -0.5% | +100.0% | -110.1% | – | – | – | |
| IMAImageneBio Inc | $46.6M | -1.4% | 0.0% | 0% | – | – | – | |
| 同行中位数 | – | – | 0.0% | 0% | 1.9x | 2.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。